Kaisernetwork.org is no longer publishing new content as of June 1, 2009.

The Kaiser Family Foundation continues to provide webcasts, podcasts and transcripts of Kaiser's events along with health policy briefings on the Hill conducted by the Alliance for Health Reform. You may access these webcasts, along with Kaiser's original videos and documentaries, on kff.org. All archived webcasts, podcasts and transcripts made available on kaisernetwork.org prior to June 1, 2009, continue to be available on-demand. You may search for webcasts here.

We have detected that your browser blocked our video player. Please enable popups and try again. Thank you. Search for webcasts from November 2000 – May 2009. Access webcasts from June 2009 forward, on kff.org. Open Forum II: Key Issues in TB Drug Development - Day Two 12/13/2006 TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group, Stop TB Partnership Working Group on New Drugs, London, England     Email this Webcast Share Del.icio.us Digg Facebook Google Bookmarks Myspace Reddit   Support Files Basri Slides (.pdf) Chaisson Slides (.pdf) Chin Slides (.pdf) Dalcolmo Slides (.pdf) Diacon Slides (.pdf) Horsburgh Slides (.pdf) Jaramillo Slides (.pdf) Ma Slides (.pdf) Additional Resources Kaisernetwork.org Coverage of the 37th Union World Conference on Lung Health GlobalHealthReporting.org - Tuberculosis GlobalHealthFacts.org GlobalHealthReporting.org Weekly TB/Malaria Report **Please note: Some sessions are still pending approval for posting and will be available at another date.   This two-day forum, hosted by the TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group and the Stop TB Partnership Working Group on New Drugs, is the second in a series of meetings addressing key issues in TB drug development. This forum includes sessions on key issues in the critical path to TB drug registration, biomarkers for TB drug development, designing pivotal trials, conducting registration trials in high burden countries and developing regimens containing multiple novel agents.   December 12 Sessions **Pending approval to post webcast Speakers for this session:   Welcome and Introductions to Day Two Richard Chaisson, M.D. Director Johns Hopkins Medicine Center for Tuberculosis Research Moderator     EMEA Scientific Advice Procedure Jordi Llinares European Medicines Agency Full version: Video Transcript Speakers for this session:   Developing Combination Regimens Containing Multiple Novel Drugs Zhenkun Ma, Ph.D. Head, Research TB Alliance Full version: Video Transcript Speakers for this session:   Challenges of Conducting Trials in High Burden Country Settings Richard Chaisson, M.D. Director Johns Hopkins University, School of Medicine Moderator   Javid Syed TB/HIV Project Director Treatment Action Group Roxana Rustomjee King George V Hospital Christian Lienhardt, M.D. International Union Against Tuberculosis and Lung Disease  Institut de Recherche pour le Development Andreas Diacon Department of Internal Medicine, Tygerberg Academic Hospital University of Stellenbosch   Margareth Ndomondo-Sigonda Director-General Tanzania FDA   Granville Garcia de Oliveira Manager. New Drugs, Research and Clinical Trials ANVISA Full version: Video Transcript Speakers for this session:   Opportunities and Challenges For an M(X)DR Clinical Development Program Ernesto Jaramillo Stop TB Working Group on MDR TB World Health Organization C. Robert Horsburgh, Jr. Chair, Epidemiology Boston University School of Public Health     **Pending approval to post webcast Speakers for this session:   Issues Associated with Compassionate Use Richard Chaisson, M.D. Director Johns Hopkins University, School of Medicine Moderator Ernesto Jaramillo Stop TB Working Group on MDR TB World Health Organization Maura Linda Sitanggang National Agency of Drug and Food Control, Indonesia Francis Varaine Head, TB Unit Medecins Sans Frontiers C. Robert Horsburgh, Jr. Chair, Epidemiology Boston University School of Public Health **Pending approval to post webcast Speakers for this session:   A Case Study: Paths to Registering and Adopting Novel TB Treatments in India – The Roles of Government NK Ganguly Director-General Indian Council of Medical Research Full version: Video Transcript Speakers for this session:   Adoption of Improved TB Treatment Regimens – What is Needed and What is Feasible from Endemic Country Perspectives? Richard Chaisson, M.D. Director Johns Hopkins University, School of Medicine Moderator Lucy Chesire Kenya Community Representative  Coordinating Board, STOP TB Partnership Daniel Chin China Office WHO Margareth Dalcolmo Ministry of Health, Brazil Carmelia Basri NTP Indonesia EMAIL ALERTS Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.   FAQs How to disable a pop-up blocker How to view a webcast How to listen to a podcast More...   CONTACT US Contact us by email with any comments, problems, suggestions. Call the kaisernetwork.org Help Desk at 202-347-5270. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... About Us     Help